LY. Hsu, SC. Chang; KT. Luh; WC. Hsieh, Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production., in Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, vol. 24, n. 3, agosto 1991, pp. 272-80, PMID1818798.
ID. Farrell, PJ. Turner, Augmentin: laboratory studies., in Scott Med J, 27 Spec No., 1982, pp. S21-3, PMID6762661.
GN. Rolinson, The history and background of Augmentin., in S Afr Med J, vol. 62, 5 Spec No, luglio 1982, pp. 3A-4A, PMID6979804.
GE. Stein, MJ. Gurwith, Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination., in Clin Pharm, vol. 3, n. 6, Nov-Dic 1984, pp. 591-9, PMID6391783.
F. Fraschini, F. Scaglione; M. Falchi; S. Dugnani; M. Mezzetti; F. Cicchetti; G. Alfano; GP. Pintucci, Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man., in J Chemother, vol. 2, n. 3, giugno 1990, pp. 171-7, PMID2199627.
G. Witkowski, H. Lode; G. Höffken; P. Koeppe, Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination., in Eur J Clin Microbiol, vol. 1, n. 4, agosto 1982, pp. 233-7, PMID7173186.
RJ. Grimer, MR. Karpinski; JM. Andrews; R. Wise, Penetration of amoxycillin and clavulanic acid into bone., in Chemotherapy, vol. 32, n. 3, 1986, pp. 185-91, PMID3486754.
KE. Ferslew, EA. Daigneault; EM. Aten; JM. Roseman, Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate., in J Clin Pharmacol, vol. 24, n. 10, ottobre 1984, pp. 452-6, PMID6511988.
RN. Brogden, A. Carmine; RC. Heel; PA. Morley; TM. Speight; GS. Avery, Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use., in Drugs, vol. 22, n. 5, novembre 1981, pp. 337-62, PMID7037354.
E. Leibovitz, D. Greenberg, Acute otitis media in children: current epidemiology, microbiology, clinical manifestations, and treatment., in Chang Gung Med J, vol. 27, n. 7, luglio 2004, pp. 475-88, PMID15508870.
F. Alvarez, E. Bouza; JA. García-Rodríguez; J. Mensa; E. Monsó; JJ. Picazo; V. Sobradillo; A. Torres; M. Moya Mir; M. Martínez Ortiz De Zárate; F. Pérez Escanilla, [Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease]., in Arch Bronconeumol, vol. 39, n. 6, giugno 2003, pp. 274-82, PMID12797944.
M. Caramia, G. Taddei; A. Nobilini, [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy]., in Minerva Pediatr, vol. 42, n. 1-2, pp. 29-34, PMID2186263.
HC. Neu, AP. Wilson; RN. Grüneberg, Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992., in J Chemother, vol. 5, n. 2, aprile 1993, pp. 67-93, PMID8515298.
PL. McCormack, GM. Keating, Amoxicillin/clavulanic acid 2000mg/125mg extended release (XR): a review of its use in the treatment of respiratory tract infections in adults., in Drugs, vol. 65, n. 1, 2005, pp. 121-36, PMID15610061.
U. Gresser, Amoxicillin-clavulanic acid therapy may be associated with severe side effects -- review of the literature., in Eur J Med Res, vol. 6, n. 4, aprile 2001, pp. 139-49, PMID11309226.
JW. van den Broek, BL. Buennemeyer; BH. Stricker, [Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)]., in Ned Tijdschr Geneeskd, vol. 132, n. 32, agosto 1988, pp. 1495-7, PMID3173514.
MK. Belknap, KJ. McClelland, Cholestatic hepatitis associated with amoxicillin-clavulanate., in Wis Med J, vol. 92, n. 5, maggio 1993, pp. 241-2, PMID8328159.